Landmark Trials in Heart Failure

Several landmark clinical trials have significantly influenced the management and understanding of heart failure over the years. These trials have provided crucial evidence for the efficacy and safety of various treatment strategies. Here are some notable landmark trials:

SOLVD (Studies of Left Ventricular Dysfunction): SOLVD demonstrated the benefits of angiotensin-converting enzyme (ACE) inhibitors in reducing mortality and hospitalizations in patients with heart failure and reduced ejection fraction.

MERIT-HF (Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure): This trial highlighted the benefits of beta-blockers, specifically metoprolol, in improving survival and reducing hospitalizations in patients with heart failure and reduced ejection fraction.

CIBIS (Cardiac Insufficiency Bisoprolol Study) and COPERNICUS (Carvedilol Prospective Randomized Cumulative Survival): These trials demonstrated the benefits of beta-blockers (bisoprolol and carvedilol, respectively) in reducing mortality and hospitalizations in heart failure patients.

EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure): This trial showed that adding the mineralocorticoid receptor antagonist eplerenone to standard therapy reduced the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure and reduced ejection fraction.

PARADIGM-HF (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure): This trial demonstrated the superiority of angiotensin receptor-neprilysin inhibitor (ARNI) over ACE inhibitors in reducing mortality and hospitalizations in heart failure patients with reduced ejection fraction.

These landmark trials have shaped current heart failure treatment guidelines and have significantly improved outcomes for patients with heart failure, providing evidence-based strategies that have become the standard of care.

    Related Conference of Landmark Trials in Heart Failure

    April 16-17, 2025

    8th World Heart and Brain Conference

    Tokyo, Japan
    April 24-25, 2025

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    April 28-29, 2025

    37th World Congress on Cardiology & Heart Diseases

    Frankfurt, Germany
    April 28-29, 2025

    39th World Congress on Heart Diseases

    Frankfurt, Germany
    May 19-20, 2025

    4th International Conference on Cardiology

    Rome, Italy
    May 22-23, 2025

    5th World Congress on Congestive Heart Failure & Angina

    Zurich, Switzerland
    May 26-27, 2025

    6th European Summit on Cardiology Research

    Rome, Italy
    August 11-12, 2025

    3rd International Conference on World Heart Care

    Toronto, Canada
    August 19-20, 2025

    29th World Cardiology Conference

    Paris, France
    August 21-22, 2025

    8th Global Cardiovascular Research and Clinical Cardiology

    Vancouver, Canada
    September 08-09, 2025

    39th European Cardiology Conference

    Frankfurt, Germany
    September 22-23, 2025

    7th Annual Conference on Vascular Medicine

    Amsterdam, Netherlands
    September 22-23, 2025

    14th World Heart Congress

    Dubai, UAE
    September 25-26, 2025

    13th International Conference on Hypertension and Healthcare

    Zurich, Switzerland
    November 13-14, 2025

    6th Global Summit on Heart Congress

    Paris, France
    November 19-20, 2025

    7th Euro Heart Congress

    Tokyo, Japan
    November 24-25, 2025

    36th Annual Cardiologists Conference

    Barcelona, Spain

    Landmark Trials in Heart Failure Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in